» Articles » PMID: 35016612

The Probable Role and Therapeutic Potential of the PI3K/AKT Signaling Pathway in SARS-CoV-2 Induced Coagulopathy

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is associated with a high mortality rate. The majority of deaths in this disease are caused by ARDS (acute respiratory distress syndrome) followed by cytokine storm and coagulation complications. Although alterations in the level of the number of coagulation factors have been detected in samples from COVID-19 patients, the direct molecular mechanism which has been involved in this pathologic process has not been explored yet. The PI3K/AKT signaling pathway is an intracellular pathway which plays a central role in cell survival. Also, in recent years the association between this pathway and coagulopathies has been well clarified. Therefore, based on the evidence on over-activity of the PI3K/AKT signaling pathway in SARS-CoV-2 infection, in the current review, the probable role of this cellular pathway as a therapeutic target for the prevention of coagulation complications in patients with COVID-19 is discussed.

Citing Articles

Neurological complications caused by SARS-CoV-2.

Pang Z, Tang A, He Y, Fan J, Yang Q, Tong Y Clin Microbiol Rev. 2024; 37(4):e0013124.

PMID: 39291997 PMC: 11629622. DOI: 10.1128/cmr.00131-24.


Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.

Ashayeri Ahmadabad H, Mohammadi Panah S, Ghasemnejad-Berenji H, Ghojavand S, Ghasemnejad-Berenji M, Khezri M Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1035-1055.

PMID: 39225830 DOI: 10.1007/s00210-024-03358-3.


Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication.

De Antonellis P, Ferrucci V, Miceli M, Bibbo F, Asadzadeh F, Gorini F EMBO Rep. 2024; 25(7):2974-3007.

PMID: 38816514 PMC: 11239940. DOI: 10.1038/s44319-024-00164-z.


Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution.

Kassis G, Palshikar M, Hilchey S, Zand M, Thakar J J Theor Biol. 2024; 583:111769.

PMID: 38423206 PMC: 11046450. DOI: 10.1016/j.jtbi.2024.111769.


RUNX1 targeting AKT3 promotes alveolar hypercoagulation and fibrinolytic inhibition in LPS induced ARDS.

Xiao C, Liu J, Cheng Y, Wu Y, Li Q, Chen X Respir Res. 2024; 25(1):54.

PMID: 38267920 PMC: 10809548. DOI: 10.1186/s12931-024-02689-2.


References
1.
He Z, Khatib A, Creemers J . Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast Cancer. Cancers (Basel). 2020; 12(9). PMC: 7563341. DOI: 10.3390/cancers12092686. View

2.
Huang C, Lin H, Chen H, Cheng S, Hsu H, Tang C . Thrombin promotes matrix metalloproteinase-13 expression through the PKCδ c-Src/EGFR/PI3K/Akt/AP-1 signaling pathway in human chondrocytes. Mediators Inflamm. 2014; 2013:326041. PMC: 3872103. DOI: 10.1155/2013/326041. View

3.
Blair T, Moore S, Walsh T, Hutchinson J, Durrant T, Anderson K . Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation. Cell Signal. 2018; 50:111-120. DOI: 10.1016/j.cellsig.2018.05.005. View

4.
Sun F, Mu C, Kwok H, Xu J, Wu Y, Liu W . Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int J Biol Sci. 2021; 17(9):2348-2355. PMC: 8241724. DOI: 10.7150/ijbs.57810. View

5.
Anselmo A, Riva F, Gentile S, Soldani C, Barbagallo M, Mazzon C . Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets. Cardiovasc Res. 2016; 111(4):373-84. DOI: 10.1093/cvr/cvw162. View